Curves fitted using the cylindrical diffusion model for cumulative in vitro release profiles of (a) BSA and (b) siRNA at pH 5 and pH 7.4.

Spatial-temporal evolution of the drug concentration in the tumor model.

Hang Xie (218360)
Yang Jiao (147576)
Qihui Fan (1867066)
Miaomiao Hai (5900576)
Jiaen Yang (778079)
Zhijian Hu (1528558)
Yue Yang (52715)
Jianwei Shuai (773992)
Guo Chen (182090)
Ruchuan Liu (472818)
Liyu Liu (339838)

October 2018

(a) and (b) the drug concentration distribution in an ideal tumor with r0 = 0.2 cm and σ = 0.01 cm. ...

Pharmacokinetic parameters of the imaging agents derived from a two-compartmental model.

Jeerapond Leelawattanachai (728471)
Keon-Woo Kwon (728472)
Praveesuda Michael (728473)
Richard Ting (728474)
Ju-Young Kim (56051)
Moonsoo M. Jin (309286)

April 2015

*t = 168 h for IgG, t = 24 h for Fab, BSA and Streptavidin. Notations and abbreviations: distribu...

Concentration-time profiles of LRS and LRI with and without endocytic downregulation.

Pilar García-Peñarrubia (348167)
Juan J. Gálvez (348169)
Jesús Gálvez (348172)

February 2013

Concentration-time profiles of LRS and LRI computed at two values of the endocytic downregulation...

Model fitting for siRNA/BSA release profiles from CA-PEI micelles at pH 5 and 7.4.

M. Wahab Amjad (617442)
Mohd Cairul I. Mohd Amin (617443)
Shalela M. Mahali (617444)
Haliza Katas (617445)
Ismanizan Ismail (617446)
M. Naeem ul Hassan (617447)
Victor T. Giam Chuang (617448)

August 2014

Model fitting for siRNA/BSA release profiles from CA-PEI micelles at pH 5 and 7.4.</p

Drug release curve of RFP/PDLLA/nHA composite.

JunFeng Dong (553026)
ShengMin Zhang (553027)
Jun Ma (9393)
HaoMing Liu (553028)
YingYing Du (553029)
YongHui Liu (5658727)

April 2014

A: Standard curve of RFP in PBS. B: Drug release curve of RFP in PBS. C: The relationship between...

Calibration of model parameters to in vitro experiments.

Adrianne L. Jenner (11133854)
Wayne Kelly (8575101)
Michael Dallaston (14439694)
Robyn Araujo (14439697)
Isobelle Parfitt (14439700)
Dominic Steinitz (14439703)
Pantea Pooladvand (13951074)
Peter S. Kim (6873146)
Samantha J. Wade (14439706)
Kara L. Vine (2472004)

January 2023

(A) Drug release profiles for gemcitabine with 3% alginate 15% PCL were measured by placing the gemc...

Growth kinetics (upper panel) and spatial profiles of TUNEL, Ki67, Collagen IV for [G] = 5mM, [O] = 0.28mM (condition II, upper right picture and middle panel) and [G] = 25mM, [O] = 0.28mM (condition III, upper left picture and low panel.).

Nick Jagiella (527549)
Benedikt Müller (459395)
Margareta Müller (849832)
Irene E. Vignon-Clementel (849833)
Dirk Drasdo (527550)

February 2016

The dotted curves show simulations where cell cycle progression requires the product of local glu...

International Biometric Society A DIFFERENTIAL EQUATIONS APPROACH TO IN VITRO – IN VIVO CORRELATION MODELLING

Clare Gaynor
Adrian Dunne
John Davis

March 2015

In vitro drug dissolution-time profiles can be used to predict in vivo drug plasma concentration-tim...

Representative TMA+-diffusion curves under resting conditions and during cell swelling.

Lesia Dmytrenko (431060)
Michal Cicanic (431061)
Miroslava Anderova (155561)
Ivan Vorisek (431062)
Ole Petter Ottersen (431063)
Eva Sykova (431064)
Lydia Vargova (431065)

July 2013

TMA+-diffusion curves with the corresponding values of the extracellular volume fracti...

Influence of model parameters on copy number and concentration distributions.

Chen Jia (2794714)
Abhyudai Singh (503811)
Ramon Grima (319683)

October 2022

A-C: The copy number (red curve) and concentration (blue curve) distributions display different shap...

Mathematical techniques for the estimation of the diffusion coefficient and elimination constant of agents in subcutaneous tissue

Hersh, Lawrence T

June 2007

The purpose of this work was to develop methods to estimate the diffusion coefficient and eliminatio...

Dispersion curves for various inhibitor degradation rates (a) and for various activator diffusion rates (b) in classical GM model.

Alexey M. Nesterenko (3186423)
Maxim B. Kuznetsov (3723427)
Daria D. Korotkova (3723424)
Andrey G. Zaraisky (28133)

February 2017

Dispersion curves are plotted using formula obtained in Eq (S1.2.6). Following parameters are use...

Model structure and performance.

Julia Caldwell (792878)
Weijia Wang (190138)
Peter W. Zandstra (79978)

September 2015

[A] Cumulative growth curves are defined for each phenotype group to calculate expansion a...

Experimental release profiles of CF from vesicles at 45°C.

Gabriel Piedrafita (155328)
Kepa Ruiz-Mirazo (155337)
Pierre-Alain Monnard (155348)
Athel Cornish-Bowden (155356)
Francisco Montero (155363)

June 2012

(A) Time evolution of the concentration of released CF, normalized to the concentration at equili...

A biphasic diffusion model of drug release from medical implant coatings

Quirk, Keelin

Vascular diseases remain one of the leading causes of death worldwide. Two common treatments for suc...

Spatial-temporal evolution of the drug concentration in the tumor model.

Hang Xie (218360)
Yang Jiao (147576)
Qihui Fan (1867066)
Miaomiao Hai (5900576)
Jiaen Yang (778079)
Zhijian Hu (1528558)
Yue Yang (52715)
Jianwei Shuai (773992)
Guo Chen (182090)
Ruchuan Liu (472818)
Liyu Liu (339838)

October 2018

(a) and (b) the drug concentration distribution in an ideal tumor with r0 = 0.2 cm and σ = 0.01 cm. ...

Pharmacokinetic parameters of the imaging agents derived from a two-compartmental model.

Jeerapond Leelawattanachai (728471)
Keon-Woo Kwon (728472)
Praveesuda Michael (728473)
Richard Ting (728474)
Ju-Young Kim (56051)
Moonsoo M. Jin (309286)

April 2015

*t = 168 h for IgG, t = 24 h for Fab, BSA and Streptavidin. Notations and abbreviations: distribu...

Concentration-time profiles of LRS and LRI with and without endocytic downregulation.

Pilar García-Peñarrubia (348167)
Juan J. Gálvez (348169)
Jesús Gálvez (348172)

February 2013

Concentration-time profiles of LRS and LRI computed at two values of the endocytic downregulation...

Model fitting for siRNA/BSA release profiles from CA-PEI micelles at pH 5 and 7.4.

M. Wahab Amjad (617442)
Mohd Cairul I. Mohd Amin (617443)
Shalela M. Mahali (617444)
Haliza Katas (617445)
Ismanizan Ismail (617446)
M. Naeem ul Hassan (617447)
Victor T. Giam Chuang (617448)

August 2014

Model fitting for siRNA/BSA release profiles from CA-PEI micelles at pH 5 and 7.4.</p

Drug release curve of RFP/PDLLA/nHA composite.

JunFeng Dong (553026)
ShengMin Zhang (553027)
Jun Ma (9393)
HaoMing Liu (553028)
YingYing Du (553029)
YongHui Liu (5658727)

April 2014

A: Standard curve of RFP in PBS. B: Drug release curve of RFP in PBS. C: The relationship between...

Calibration of model parameters to in vitro experiments.

Adrianne L. Jenner (11133854)
Wayne Kelly (8575101)
Michael Dallaston (14439694)
Robyn Araujo (14439697)
Isobelle Parfitt (14439700)
Dominic Steinitz (14439703)
Pantea Pooladvand (13951074)
Peter S. Kim (6873146)
Samantha J. Wade (14439706)
Kara L. Vine (2472004)

January 2023

(A) Drug release profiles for gemcitabine with 3% alginate 15% PCL were measured by placing the gemc...

Growth kinetics (upper panel) and spatial profiles of TUNEL, Ki67, Collagen IV for [G] = 5mM, [O] = 0.28mM (condition II, upper right picture and middle panel) and [G] = 25mM, [O] = 0.28mM (condition III, upper left picture and low panel.).

Nick Jagiella (527549)
Benedikt Müller (459395)
Margareta Müller (849832)
Irene E. Vignon-Clementel (849833)
Dirk Drasdo (527550)

February 2016

The dotted curves show simulations where cell cycle progression requires the product of local glu...

International Biometric Society A DIFFERENTIAL EQUATIONS APPROACH TO IN VITRO – IN VIVO CORRELATION MODELLING

Clare Gaynor
Adrian Dunne
John Davis

March 2015

In vitro drug dissolution-time profiles can be used to predict in vivo drug plasma concentration-tim...

Representative TMA+-diffusion curves under resting conditions and during cell swelling.

Lesia Dmytrenko (431060)
Michal Cicanic (431061)
Miroslava Anderova (155561)
Ivan Vorisek (431062)
Ole Petter Ottersen (431063)
Eva Sykova (431064)
Lydia Vargova (431065)

July 2013

TMA+-diffusion curves with the corresponding values of the extracellular volume fracti...

Influence of model parameters on copy number and concentration distributions.

Chen Jia (2794714)
Abhyudai Singh (503811)
Ramon Grima (319683)

October 2022

A-C: The copy number (red curve) and concentration (blue curve) distributions display different shap...

Mathematical techniques for the estimation of the diffusion coefficient and elimination constant of agents in subcutaneous tissue

Hersh, Lawrence T

June 2007

The purpose of this work was to develop methods to estimate the diffusion coefficient and eliminatio...

Dispersion curves for various inhibitor degradation rates (a) and for various activator diffusion rates (b) in classical GM model.

Alexey M. Nesterenko (3186423)
Maxim B. Kuznetsov (3723427)
Daria D. Korotkova (3723424)
Andrey G. Zaraisky (28133)

February 2017

Dispersion curves are plotted using formula obtained in Eq (S1.2.6). Following parameters are use...

Model structure and performance.

Julia Caldwell (792878)
Weijia Wang (190138)
Peter W. Zandstra (79978)

September 2015

[A] Cumulative growth curves are defined for each phenotype group to calculate expansion a...

Experimental release profiles of CF from vesicles at 45°C.

Gabriel Piedrafita (155328)
Kepa Ruiz-Mirazo (155337)
Pierre-Alain Monnard (155348)
Athel Cornish-Bowden (155356)
Francisco Montero (155363)

June 2012

(A) Time evolution of the concentration of released CF, normalized to the concentration at equili...

A biphasic diffusion model of drug release from medical implant coatings

Quirk, Keelin

Vascular diseases remain one of the leading causes of death worldwide. Two common treatments for suc...

Spatial-temporal evolution of the drug concentration in the tumor model.

Hang Xie (218360)
Yang Jiao (147576)
Qihui Fan (1867066)
Miaomiao Hai (5900576)
Jiaen Yang (778079)
Zhijian Hu (1528558)
Yue Yang (52715)
Jianwei Shuai (773992)
Guo Chen (182090)
Ruchuan Liu (472818)
Liyu Liu (339838)

October 2018

(a) and (b) the drug concentration distribution in an ideal tumor with r0 = 0.2 cm and σ = 0.01 cm. ...

Pharmacokinetic parameters of the imaging agents derived from a two-compartmental model.

Jeerapond Leelawattanachai (728471)
Keon-Woo Kwon (728472)
Praveesuda Michael (728473)
Richard Ting (728474)
Ju-Young Kim (56051)
Moonsoo M. Jin (309286)

April 2015

*t = 168 h for IgG, t = 24 h for Fab, BSA and Streptavidin. Notations and abbreviations: distribu...

Concentration-time profiles of LRS and LRI with and without endocytic downregulation.

Pilar García-Peñarrubia (348167)
Juan J. Gálvez (348169)
Jesús Gálvez (348172)

February 2013

Concentration-time profiles of LRS and LRI computed at two values of the endocytic downregulation...

Curves fitted using the cylindrical diffusion model for cumulative <i>in vitro</i> release profiles of (a) BSA and (b) siRNA at pH 5 and pH 7.4.

Abstract

Extracted data

Curves fitted using the cylindrical diffusion model for cumulative <i>in vitro</i> release profiles of (a) BSA and (b) siRNA at pH 5 and pH 7.4.

Abstract

Extracted data

Related items

Related items